Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

cma-logo-v3

UK watchdog finds drug firms colluded to hike essential NHS medication by 1,800%

October 4, 2019 Medical Communications

The UK’s Competition and Markets Authority (CMA) has provisionally found that three drug firms signed an illegal agreement which led …
News
astrazeneca_building_white

FDA approves single-use auto-injector form of IL-5 inhibitor Fasenra

October 4, 2019 Medical Communications, Sales and Marketing AstraZeneca, FDA, Fasenra, pharma

AstraZeneca is celebrating as the FDA announced the approval of its IL-5 inhibitor Fasenra  (benralizumab) in a pre-filled, single-use auto-injector …
News
gilead-sciences

FDA approves second PrEP drug to prevent HIV infection

October 4, 2019 Medical Communications

The US FDA has approved Gilead’s Descovy (emtricitabine/tenofovir alafenamide) as a second pre-exposure prophylaxis (PrEP) drug in at-risk adults and …
News
servier

Servier gains non-Hodgkin lymphoma drug from CTI BioPharma

October 3, 2019 Medical Communications, Sales and Marketing

French pharma-giant Servier has purchased the medication Pixuvri, indicated for the treatment of non-Hodgkin B-cell lymphoma, from US-based CTI BioPharma. …
News
emma-walmsley-big

GSK Chief Emma Walmsley voices support for equal pay campaign

October 3, 2019 Medical Communications Emma Walmsley, GSK, GlaxoSmithKline, pharma

GlaxoSmithKline Chief Emma Walmsley has joined the chorus of more than a hundred of the UK’s most successful female business …
News
sandrock-al-e1548286908776

Biogen announces leadership updates

October 2, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Biogen have announced updates to it senior leadership team with Alfred Sandrock being named Executive Vice President of Research and …
Appointment
dave_peacock

MSD announce David Peacock as new Managing Director in UK and Ireland

October 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

MSD have announced that David Peacock will become Managing Director in the UK and Ireland, succeeding former director Louise Houson, …
Appointment

Chris Whitty begins role as England’s Chief Medical Officer

October 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

London consultant and public health professor, Chris Whitty, has begun his role as England’s Chief Medical Officer, taking over from …
Appointment
albert_bourla2019_300x170_1

Pfizer CEO Albert Bourla to Succeed Ian Read as Executive Chairman

September 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer’s executive chairman Ian Read, is to be succeeded by CEO Albert Bourla with a date to start the post …
Appointment
shutterstock

The world needs a better plan for cancer survival by 2030

September 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Roche, UN General Assembly, United Nations, feature, opinion, pharma

Beginning on 24 September, the UN will convene in New York for its annual General Assermbly. Dr Christian Rommel, Roche´s …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 27, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

Another week comes to a close, and it’s time to review the biggest stories of the week. Check out the …
News
takeda_deerfield_hq

Takeda’s Entyvio outperforms AbbVie’s Humira in moderate-to-severe ulcerative colitis

September 27, 2019 Medical Communications, Research and Development AbbVie, Entyvio, Humira, Takeda, pharma, ulcerative colitis

Takeda has released strong new data for Entyvio (vedolizumab), showing that the gut-selective biologic outperformed AbbVie’s blockbuster anti-tumour necrosis factor-alpha …
News
abbvie_0

AbbVie’s Mavyret scores FDA label expansion to shorten treatment duration for hepatitis C patients

September 27, 2019 Medical Communications, Sales and Marketing AbbVie, FDA, hepatitis, hepatitis C, mavyret, pharma

The FDA has chosen to expand the existing label for AbbVie’s Mavyret (glecaprevir/pibrentasvir), it has been revealed, to include the …
News
darzalex-product-shot---100mg-vial-2-hr

FDA approves Genmab’s Darzalex combo in newly diagnosed multiple myeloma

September 27, 2019 Medical Communications, Sales and Marketing FDA, Genmab, darzalex, pharma

Genmab’s CD38 inhibitor Darzalex (daratumumab) has been awarded marketing authorisation from the FDA in combination with bortezomib, thalidomide and dexamethasone …
News
Catapult Stevenage site

Cell and Gene Therapy Catapult doubles capacity at UK site

September 26, 2019 Manufacturing and Production, Medical Communications

The United Kingdom’s Cell and Gene Therapy Catapult (CGT Catapult) has added six additional modules of cleanroom space at its …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026